Vaxcyte Inc’s filing revealed that its CHIEF EXECUTIVE OFFICER PICKERING GRANT unloaded Company’s shares for reported $0.93 million on Apr 23 ’24. In the deal valued at $61.92 per share,15,000 shares were sold. As a result of this transaction, PICKERING GRANT now holds 477,847 shares worth roughly $29.01 million.
Then, GUGGENHIME ANDREW sold 8,000 shares, generating $490,199 in total proceeds. Upon selling the shares at $61.27, the PRESIDENT AND CFO now owns 95,679 shares.
Before that, Wassil Jim sold 3,000 shares. Vaxcyte Inc shares valued at $200,066 were divested by the CHIEF OPERATING OFFICER at a price of $66.69 per share. As a result of the transaction, Wassil Jim now holds 218,289 shares, worth roughly $13.25 million.
Mizuho initiated its Vaxcyte Inc [PCVX] rating to a Buy in a research note published on December 07, 2023; the price target was $69. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid April with a ‘”an Outperform”‘ rating. Needham also remained covering PCVX and reiterated its “Buy” recommendation on January 03, 2023. Guggenheim started covering the stock on December 15, 2022. It rated PCVX as “a Buy”.
Price Performance Review of PCVX
On Friday, Vaxcyte Inc [NASDAQ:PCVX] saw its stock jump 1.10% to $60.72. Over the last five days, the stock has lost -0.18%. Vaxcyte Inc shares have fallen nearly -3.31% since the year began. Nevertheless, the stocks have risen 44.57% over the past one year. While a 52-week high of $82.04 was reached on 02/28/24, a 52-week low of $41.57 was recorded on 01/05/24. SMA at 50 days reached $68.09, while 200 days put it at $57.62. A total of 0.59 million shares were traded, compared to the trading of 0.7 million shares in the previous session.
Levels Of Support And Resistance For PCVX Stock
The 24-hour chart illustrates a support level at 59.77, which if violated will result in even more drops to 58.82. On the upside, there is a resistance level at 61.31. A further resistance level may holdings at 61.89. The Relative Strength Index (RSI) on the 14-day chart is 37.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.49, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.51%. Stochastics %K at 26.41% indicates the stock is a holding.
The most recent change occurred on November 17, 2022 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $69 price target.
